Article
Healthcare & Life Sciences Private Equity Deal Tracker: Ampersand Acquires Nektar Therapeutics' PEGylation
Ampersand Capital Partners has announced its acquisition of Nektar Therapeutics' PEGylation reagent manufacturing business.

McGuireWoods LLP
